Jérôme Lambert

Bortezomib, thalidomide, and dexamethasone with or without daratumumab before and after autologous stem-cell transplantation for newly diagnosed multiple myeloma (CASSIOPEIA): a randomised, open-label, phase 3 study

Philippe Moreau, Michel Attal, Cyrille Hulin et al. · The Lancet · 2019 · 922 citations · Full text

Hematological Malignancy, Radiation Oncology, Medicine +9

Outcomes of Critically Ill Patients With Hematologic Malignancies: Prospective Multicenter Data From France and Belgium—A Groupe de Recherche Respiratoire en Réanimation Onco-Hématologique Study

Élie Azoulay, Djamel Mokart, Frédéric Pène et al. · Journal of Clinical Oncology · 2013 · 614 citations · Full text

Critical Care Management, Critically Ill Patients, Critical Care Medicine +15

Diagnostic Strategy for Hematology and Oncology Patients with Acute Respiratory Failure

Élie Azoulay, Djamel Mokart, Jérôme Lambert et al. · American Journal of Respiratory and Critical Care Medicine · 2010 · 296 citations

Toward a <i>NOTCH1/FBXW7/RAS/PTEN</i> –Based Oncogenetic Risk Classification of Adult T-Cell Acute Lymphoblastic Leukemia: A Group for Research in Adult Acute Lymphoblastic Leukemia Study

Amélie Trinquand, Aline Schmidt, Raouf Ben Abdelali et al. · Journal of Clinical Oncology · 2013 · 246 citations · Full text

Acquired Initiating Mutations in Early Hematopoietic Cells of CLL Patients

Frédérik Damm, Elena Mylonas, Adrien Cosson et al. · Cancer Discovery · 2014 · 243 citations